Connection

Franco Locatelli to Male

This is a "connection" page, showing publications Franco Locatelli has written about Male.
Connection Strength

0.279
  1. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases. Front Immunol. 2020; 11:610300.
    View in: PubMed
    Score: 0.012
  2. HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients. HLA. 2020 11; 96(5):610-614.
    View in: PubMed
    Score: 0.012
  3. Role of interferon-? in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation. Haematologica. 2019 11; 104(11):2314-2323.
    View in: PubMed
    Score: 0.011
  4. Unrelated donor vs HLA-haploidentical a/ß T-cell- and B-cell-depleted HSCT in children with acute leukemia. Blood. 2018 12 13; 132(24):2594-2607.
    View in: PubMed
    Score: 0.011
  5. Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. Lancet Haematol. 2018 Oct; 5(10):e450-e461.
    View in: PubMed
    Score: 0.011
  6. Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia. Br J Haematol. 2019 04; 185(2):360-363.
    View in: PubMed
    Score: 0.011
  7. How I treat myelodysplastic syndromes of childhood. Blood. 2018 03 29; 131(13):1406-1414.
    View in: PubMed
    Score: 0.010
  8. Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy. Biol Blood Marrow Transplant. 2018 06; 24(6):1223-1231.
    View in: PubMed
    Score: 0.010
  9. Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia. Expert Rev Hematol. 2018 02; 11(2):129-143.
    View in: PubMed
    Score: 0.010
  10. Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL. Blood. 2017 11 09; 130(19):2146-2149.
    View in: PubMed
    Score: 0.010
  11. Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2017 08; 18(8):1126-1136.
    View in: PubMed
    Score: 0.010
  12. Outcome of children with acute leukemia given HLA-haploidentical HSCT after aß T-cell and B-cell depletion. Blood. 2017 08 03; 130(5):677-685.
    View in: PubMed
    Score: 0.010
  13. A New Enzyme-Linked Immunosorbent Assay for a Total Anti-T Lymphocyte Globulin Determination: Development, Analytical Validation, and Clinical Applications. Ther Drug Monit. 2017 06; 39(3):282-289.
    View in: PubMed
    Score: 0.010
  14. The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood. Br J Haematol. 2017 02; 176(4):629-636.
    View in: PubMed
    Score: 0.009
  15. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood. 2005 Jan 01; 105(1):410-9.
    View in: PubMed
    Score: 0.004
  16. The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients. Int J Infect Dis. 2021 Apr; 105:49-53.
    View in: PubMed
    Score: 0.003
  17. COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PLoS One. 2020; 15(12):e0244129.
    View in: PubMed
    Score: 0.003
  18. An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019. Clin Infect Dis. 2020 11 19; 71(16):2272-2275.
    View in: PubMed
    Score: 0.003
  19. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome. Cell Death Dis. 2020 10 27; 11(10):921.
    View in: PubMed
    Score: 0.003
  20. Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay. Viruses. 2020 10 20; 12(10).
    View in: PubMed
    Score: 0.003
  21. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020 12; 8(12):1201-1208.
    View in: PubMed
    Score: 0.003
  22. Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network. Front Immunol. 2019; 10:1908.
    View in: PubMed
    Score: 0.003
  23. Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study. J Clin Oncol. 2019 09 01; 37(25):2246-2256.
    View in: PubMed
    Score: 0.003
  24. Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies. Front Immunol. 2019; 10:316.
    View in: PubMed
    Score: 0.003
  25. Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency. J Allergy Clin Immunol Pract. 2019 Jul - Aug; 7(6):1970-1985.e4.
    View in: PubMed
    Score: 0.003
  26. CB2 Receptor Stimulation and Dexamethasone Restore the Anti-Inflammatory and Immune-Regulatory Properties of Mesenchymal Stromal Cells of Children with Immune Thrombocytopenia. Int J Mol Sci. 2019 Feb 28; 20(5).
    View in: PubMed
    Score: 0.003
  27. Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy Registry. Eur J Cancer. 2019 03; 110:86-97.
    View in: PubMed
    Score: 0.003
  28. Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity. J Neurol. 2019 Apr; 266(4):982-989.
    View in: PubMed
    Score: 0.003
  29. Risk factors affecting outcome of unrelated cord blood transplantation for children with familial haemophagocytic lymphohistiocytosis. Br J Haematol. 2019 02; 184(3):397-404.
    View in: PubMed
    Score: 0.003
  30. Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP). Blood Cancer J. 2018 11 15; 8(12):115.
    View in: PubMed
    Score: 0.003
  31. Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience. Acta Haematol. 2018; 140(2):105-111.
    View in: PubMed
    Score: 0.003
  32. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group. Blood. 2018 10 11; 132(15):1584-1592.
    View in: PubMed
    Score: 0.003
  33. Analysis of KIR3DP1 Polymorphism Provides Relevant Information on Centromeric KIR Gene Content. J Immunol. 2018 09 01; 201(5):1460-1467.
    View in: PubMed
    Score: 0.003
  34. Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL. Blood. 2018 07 26; 132(4):405-412.
    View in: PubMed
    Score: 0.003
  35. Late Development of FceR?neg Adaptive Natural Killer Cells Upon Human Cytomegalovirus Reactivation in Umbilical Cord Blood Transplantation Recipients. Front Immunol. 2018; 9:1050.
    View in: PubMed
    Score: 0.003
  36. Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma. Cancer Res. 2018 06 15; 78(12):3337-3349.
    View in: PubMed
    Score: 0.003
  37. ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion. Nucleic Acids Res. 2018 02 28; 46(4):2045-2059.
    View in: PubMed
    Score: 0.003
  38. Long-term results of the AIEOP MH'96 childhood Hodgkin's lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy. Leuk Lymphoma. 2018 11; 59(11):2612-2621.
    View in: PubMed
    Score: 0.003
  39. Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia. Br J Haematol. 2018 03; 180(5):680-693.
    View in: PubMed
    Score: 0.003
  40. Somatic mutations activating Wiskott-Aldrich syndrome protein concomitant with RAS pathway mutations in juvenile myelomonocytic leukemia patients. Hum Mutat. 2018 04; 39(4):579-587.
    View in: PubMed
    Score: 0.003
  41. Phenotypic and functional characterization of mesenchymal stromal cells isolated from pediatric patients with severe idiopathic nephrotic syndrome. Cytotherapy. 2018 03; 20(3):322-334.
    View in: PubMed
    Score: 0.003
  42. Low Body Mass Index Is Associated with Increased Risk of Acute GVHD after Umbilical Cord Blood Transplantation in Children and Young Adults with Acute Leukemia: A Study on Behalf of Eurocord and the EBMT Pediatric Disease Working Party. Biol Blood Marrow Transplant. 2018 04; 24(4):799-805.
    View in: PubMed
    Score: 0.003
  43. RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia. Nat Commun. 2017 12 19; 8(1):2126.
    View in: PubMed
    Score: 0.003
  44. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study. J Allergy Clin Immunol. 2018 03; 141(3):1036-1049.e5.
    View in: PubMed
    Score: 0.003
  45. Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000). J Clin Oncol. 2018 01 20; 36(3):244-253.
    View in: PubMed
    Score: 0.003
  46. High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre study. Br J Haematol. 2017 12; 179(5):772-780.
    View in: PubMed
    Score: 0.002
  47. A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemia. Br J Haematol. 2018 10; 183(2):298-301.
    View in: PubMed
    Score: 0.002
  48. Src nuclear localization and its prognostic relevance in human osteosarcoma. J Cell Physiol. 2018 Feb; 233(2):1658-1670.
    View in: PubMed
    Score: 0.002
  49. Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency. Sci Rep. 2017 08 15; 7(1):8153.
    View in: PubMed
    Score: 0.002
  50. Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2017 Nov; 23(11):1939-1948.
    View in: PubMed
    Score: 0.002
  51. Whole Genome MBD-seq reveals different CpG methylation patterns in Azacytidine-treated Juvenile Myelomonocytic Leukaemia (JMML) patients. Br J Haematol. 2018 09; 182(6):909-912.
    View in: PubMed
    Score: 0.002
  52. Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy. Ann Hematol. 2017 Sep; 96(9):1449-1456.
    View in: PubMed
    Score: 0.002
  53. Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2. Cell Death Differ. 2017 05; 24(5):889-902.
    View in: PubMed
    Score: 0.002
  54. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients. Pediatr Nephrol. 2017 08; 32(8):1433-1442.
    View in: PubMed
    Score: 0.002
  55. PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma. Clin Cancer Res. 2017 Aug 01; 23(15):4462-4472.
    View in: PubMed
    Score: 0.002
  56. Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol. Br J Haematol. 2017 04; 177(1):116-126.
    View in: PubMed
    Score: 0.002
  57. Robot-Assisted Stereotactic Biopsy of Diffuse Intrinsic Pontine Glioma: A Single-Center Experience. World Neurosurg. 2017 May; 101:584-588.
    View in: PubMed
    Score: 0.002
  58. An early-biomarker algorithm predicts lethal graft-versus-host disease and survival. JCI Insight. 2017 02 09; 2(3):e89798.
    View in: PubMed
    Score: 0.002
  59. Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group. Oncotarget. 2016 May 17; 7(20):28914-9.
    View in: PubMed
    Score: 0.002
  60. The prognostic value of biological markers in paediatric Hodgkin lymphoma. Eur J Cancer. 2016 Jan; 52:33-40.
    View in: PubMed
    Score: 0.002
  61. Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group. Blood. 2015 Apr 02; 125(14):2311-3.
    View in: PubMed
    Score: 0.002
  62. Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry. Br J Haematol. 2014 Jun; 165(5):673-81.
    View in: PubMed
    Score: 0.002
  63. Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. Clin Immunol. 2010 Aug; 136(2):269-81.
    View in: PubMed
    Score: 0.001
  64. Unrelated hematopoietic stem cell transplantation for Cernunnos-XLF deficiency. Pediatr Transplant. 2009 Sep; 13(6):785-9.
    View in: PubMed
    Score: 0.001
  65. Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia. Blood. 2008 Feb 01; 111(3):1124-7.
    View in: PubMed
    Score: 0.001
  66. Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations. Haematologica. 2007 Sep; 92(9):1186-93.
    View in: PubMed
    Score: 0.001
  67. A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group. Br J Haematol. 2002 Sep; 118(3):741-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.